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1Supporting Methods 1. Validation of breast volume, and fat-water segmentation
methods using magnetic resonance imaging (MRI) images
For each participant, three sets of images were acquired in the sagittal plane (Figure 1): A. multi-slice Dixon
images with in-plane resolution 0.74 x 0.74 mm2 and slice thickness of 7.7 mm (a phantom test object was
developed and used to calibrate the water and fat volumes); B. T1-weighted (T1-w) VIBE 3-D images, with a
voxel size of 0.76 x 0.76 x 0.90 mm3; and C. multi-slice T2-weighted (T2-w) trans-axial images, with in-plane
resolution 0.85 x 0.85 mm2 and slice thickness of 4 mm.
Breast measurements were generated from the Dixon method, T1-weight VIBE (T1-w), and T2-weighted trans-
axial (T2-W) images (Figure 1) (1).
Two different approaches were used for breast volume and fat/water segmentation. Firstly, a semi-automated
breast volume segmentation method using a fuzzy C-means algorithm was applied to the Dixon images of each
participant. Misclassified regions outside and within the breast were removed by morphological and manual
post-processing editing. For the fat-water segmentation, a modified, semi-automated Dixon-based method was
applied. Readings were completed by one observer (RD). Secondly, a fully-automated algorithm was
developed to estimate breast volume for each participant using both her T1-w and T2-w images (VaT12). The
algorithm included segmenting the breast from the foreground, locating the nipple and mid-sternum positions,
coronal profile extraction (based on the protocol for manual segmentation using Dixon images) and pectoral
muscle boundary definition. For the fat-water segmentation, a modified version of the automated Van Leemput
intensity model and spatial regularization scheme (2) was developed for T2-w images.
A comparison of MRI breast measures obtained from the Dixon and T1-w/T2-w images was conducted in 200
randomly selected women. The distribution of MRI percent water in the Dixon and T1w-/T2-w images were
comparable, with similar means and medians (Figure 2). There was a high level of agreement between quintiles
of total breast volume across the Dixon and T1-w/T2-w methods, with 76% of women being assigned to the
same quintile, and 100% to the same±1 quintile. Agreement between percent water quintiles was more
moderate, with 32% of women being assigned to the same quintile, but 89% to the same±1 quintile. However,
across methods, breast measures were highly correlated with inter-class correlations ≥0.97, P<0.0001 for both 
total volume and percent water.
The T1-w/T2-w method was applied to all participants and used in the present analysis as its segmentation
process, in contrast to the Dixon approach, is fully-automated, and hence less labour-intensive, and more
objective (i.e. observer-independent).
2Figure 1: Axial, sagittal and coronal views of each type of MRI image
A: Dixon method images, from left to right: axial, sagittal and coronal views.
B: T1-weighted VIBE (T1-w) images, from left to right: axial, sagittal and coronal views.
C: T2-weighted trans-axial (T2-W) images, from left to right: axial, sagittal and coronal views.
In the Dixon (A) and T1-w (B) images, the bright, white region represents water, and the dark, black region represents fat (or
non-water). In the T2-w (C) images, the dark, black region represents water content, and the bright, white region fat.
3Figure 2: Histograms of the distribution of total breast, fat and water volume estimates (in cm3), and of
percent water (%), per breast by type of MRI image and segmentation method (n=200)
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4Supporting Methods 2: Protocol of the Systematic Review on pre-natal exposures and
breast-tissue composition
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Title: Pre-natal exposures and breast-tissue composition
Review team:
Rachel Denholm and Isabel dos Santos Silva
Background:
Breast-tissue composition is a strong and independent biomarker of susceptibility to breast cancer (BC), which
may, like BC risk itself, be influenced by events early in life when susceptibility to carcinogens is greatest.
Objectives:
The main objective is to systematically review published data on associations between maternal, in-utero and
birth size variables and breast-tissue composition.
Specific aims are:
(i) To examine associations between maternal, in utero and birth size variables and breast-tissue
composition measures;
(ii) To identify sources of heterogeneity in study-specific estimates.
Search strategy:
We plan to identify and review all published peer-reviewed studies that meet the eligibility criteria described
below.
Eligibility criteria
Studies will be eligible if (all conditions need to be met):
 Setting: Caucasian populations
 Type of studies: original reports (primary data collection) including cohort and cross-sectional studies.
Case-control studies on breast cancer will also be eligible if restricted to controls only
 Date: article published between 1st January 1970 and 25th September 2015
 Language: any language
 Size: no restrictions will be imposed
Exclusion criteria:
Studies will be excluded if they focus on:
 non-humans
 males
 non-Caucasian women
Studies will also be excluded if reviews, conference abstracts and proceedings, and general discussion papers
Search databases:
The following electronic databases will be searched:
 Pubmed
The results and dates of each search will be recorded.
Search terms:
The search will be conducted using specific keywords to identify relevant papers.
Hand searches:
Reference lists of all included studies will be cross-checked to identify other potentially relevant studies. In
addition, reference lists of reviews, conference papers and discussions articles – which will be ineligible for the
review - will be searched and cross-checked.
5Title and abstract screening
Literature searches of the electronic databases listed above will be conducted and the resulting citations will be
downloaded to EndNote software, where duplicate citations will be removed. Any additional citations identified
through hand-searches will be added to this database.
The titles and abstracts from this initial database will be screened by one reviewer and classified using the
eligibility and exclusion criteria described above as:
 Yes, full paper to be retrieved and screened
 No, exclude
 Unclear
A sample of 10% of the abstracts will also be independently screened by a second reviewer. The reason for
exclusion of papers from the review will be documented.
Full-text screening
The full-text article for all references classified as “Yes” or “Unclear” from the abstract screen will be retrieved
and screened by one author to confirm reporting on the exposures and outcome of interest. Any exclusion of
articles from the review will be documented.
Data abstraction
A standardised data extraction form will be developed and pre-tested. Any ambiguities will be discussed and the
form amended accordingly.
Data will be extracted on the following variables:
 Study identifiers: ID, author(s), year of publication
 Characteristics of the study population: country, study design (e.g. cohort, population-based), study
period, eligibility criteria, recruitment and participation rates, and final sample size;
 Pre-natal exposures: maternal age and parity at the time of birth of the participant; maternal height;
maternal pre-pregnancy weight and gestational weight gain; maternal smoking and alcohol intake during
pregnancy; maternal contraception use; participant’s birth size measures (i.e. weight, length, ponderal
index and head circumference at birth) and gestational age; and placenta weight.
 Source/timing of collection of data on the pre-natal exposures: self-reports in adult life; parental reports
when the participants were adults; parental report when the participants were children; parental report
close to the time of birth of the participant; data extracted from hospital/obstetric records.
 Breast-tissue composition assessment: type of imaging method used (e.g. mammography, dual X-ray
absorptiometry (DXA), magnetic resonance imaging (MRI)); type of method used to quantify density
(e.g. visual inspection, semi-automated, automated); scale used (e.g. binary, categorical or continuous).
 Socio-demographic characteristics of the participants at breast-tissue composition assessment: age,
socio-economic characteristics;
 Reproductive-related variables of the participants: age at menarche; age at first birth; parity, menopausal
status, use of oral contraceptives and hormone therapy at the time of breast-tissue composition
assessment.
If there are multiple eligible papers from the same study only the one based on the largest sample size, or the one
with the most comprehensive exposure data, will be selected for inclusion in the systematic review.
Relevant data from each eligible study will be extracted independently by two reviewers. Each of them will
complete the standardised data extraction form. The two resulting databases will be compared to identify
discrepancies - these will be discussed and resolved by consensus.
Study quality assessment
The two reviewers will independently use the data extracted from each study to assess their quality using a
specifically-developed standardised quality assessment form. This assessment form will be developed to capture
three domains:
 Potential for selection bias (e.g. study design; participation rates; percentage of the study population
with both pre-natal and breast density data);
 Potential for exposure and outcome measurement errors (e.g. source and timing of collection of data on
pre-natal variables; method of breast density method used);
 Availability of data on key variables (e.g. age and BMI at time of breast density assessment)
6A list of items for each one of the three domains will be developed. For each item, papers will be allocated a
score ranging from 0 (if it does not meet the criteria or if the information provided is unclear) to a maximum to
be defined (e.g. 1, 4 or 8, depending on the specific item). The overall quality of the study will be expressed as
the sum of its item-specific scores. The higher the score the higher the methodological quality of the study, that
is the lower the risk that its findings may have been affected by bias.
Data analysis
The extracted data will be analysed in STATA (Statistical Software version 14 (StataCorp, Texas).
Basic descriptive analyses will be conducted to summarise information about the study population (e.g. by
country, type of study), source and timing of pre-natal variables collected, method used to assess breast density,
etc.
Analyses will be conducted separately for each pre-natal exposure. If appropriate, depending on the number and
characteristics of the studies included in the review, and on the data reported, pooled effect estimates of the
association between a given pre-natal exposure and density breast-tissue composition measure will be estimated
using random effects models.
To examine potential sources of heterogeneity, study-specific estimates will be stratified according to relevant
factors (e.g. age or menopausal status at mammography) and methodologically relevant variables (e.g. e.g. source
of pre-natal exposure data; method used to assess breast-tissue composition; study quality score).
Between-study heterogeneity will be formally assessed using I2 (1). The findings will be tabulated and/or
displayed graphically using forest plots.
Small study bias will be assessed via funnel plots and the Egger funnel plot asymmetry test (2).
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7Supporting Methods 3: Systematic literature review of maternal, in-utero and birth size
variables and breast-tissue composition
Search terms used in PubMed
(“mammographic density” OR “mammography” OR “breast density” OR “mammographic” OR “parenchymal
patterns”)
OR
Mammography (MeSH Term)
AND
(“birth size” OR prenatal OR perinatal OR in-utero OR “maternal health” OR “birth weight” OR “head
circumference” OR “gestational age” OR “birth length” OR “ponderal index”)
OR
(“gestational weight gain” OR “placenta” OR (“weight gain” AND pregnancy) OR “post-partum weight”)
OR
(maternal AND (height OR smoking OR BMI OR weight OR alcohol OR parity OR “age of first birth” OR
reproductive OR menarche OR contraception OR (‘mammographic density’ OR “mammography” OR “breast
density” OR “mammographic” OR “parenchymal patterns”))
OR
birth weight (MeSH Term)
OR
maternal age (MeSH Term)
Limits: Humans, 1970-Current
Data extraction
Data extraction from all eligible articles was performed independently by two of the authors (RD and IdSS) using
a specifically developed standardised data extraction form (Text S2). For each eligible paper data were extracted
on country, study years, study design, study population, sample size; average age (mean (SD) or median (IQR))
at the time of breast-tissue composition assessment, method of breast-tissue composition assessment, source and
type of pre-natal exposures investigated. Data were also extracted on other relevant covariates such as age, BMI,
menopausal status, and use of oral contraceptives (OC) and hormone therapy (HT) at the time of breast-tissue
composition assessment. If there was more than one point estimate for the association between a given pre-natal
exposure and a breast-tissue composition measure the most adjusted one was chosen for the meta-analysis.
Disagreements between authors were discussed and a consensus reached.
Study quality assessment
The quality of the papers included in the review was assessed by developing a standardized quality assessment
form based on an approach similar to that used by the Cochrane Collaboration. We scored individual parameters
based on three broad categories which were chosen to reflect the potential for (i) selection bias (4 parameters) and
(ii) measurement errors (5 parameters) and (iii) the availability of data on potential confounders (6 parameters),
as indicated below.
Minimizing selection bias
1. Study Design
Score 0 if unclear
Score 1 if opportunistic cross-sectional/case-control study
Score 2 if population-based cross-sectional/case-control study
Score 3 if cohort study (or case-control study/case-cohort study nested within a cohort study)
82. Participation rate
Score 0 if unclear
Score 1 if <70% of those eligible
Score 2 if ≥70% of those eligible 
3. Percentage of the study population with data on the pre-natal exposures of interest
Score 0 if unclear
Score 1 if <70% of study population
Score 2 if ≥70% of study population 
4. Percentage of the study population with breast-tissue composition measures
Score 0 if unclear
Score 1 if <70% of study population
Score 2 if ≥70% of study population 
Minimizing exposure and outcome measurement errors
1. Source / timing of collection of data on the pre-natal exposure variables of interest
Score 0 if unclear
Score 1 if self-reports in adult life (retrospective)
Score 2 if parental report in adult life of the participants
Score 4 if parental report during childhood of the participants
Score 6 if parental report close to the time of birth of the participants
Score 8 if data extracted from hospital/obstetric records (i.e. prospective)
2. Type of unit in which the pre-natal variable was collected
Score 0 if unclear
Score 1 if binary
Score 2 if categorical
Score 4 if quantitative
3. Type of breast images acquired
Score 0 if unclear
Score 1 if copies of analogue films
Score 2 if original analogue films
Score 3 if digital mammographic, magnetic resonance imaging, or dual X-ray absorptiometry images
(i.e. images do not require digitisation)
4. Method of breast-tissue composition assessment
Score 0 if unclear
Score 1 if subjective (e.g. Wolfe, BI-RADS, Cumulus) and not blind to the women’s characteristics (or
if not known if blind)
Score 2 if subjective but blind
Score 4 if objective (e.g. fully-automated)
5. Type of scale used in the breast-tissue composition measurements
Score 0 if unclear
Score 1 if binary
Score 4 if categorical (more than 2 - e.g. full Wolfe, BI-RADS, 6-category)
Score 8 continuous (e.g. Cumulus, ImageJ-based method)
Minimizing confounding
1. Age at the time of breast-tissue composition assessment (e.g. age at mammography)
Score 0 if not adjusted
Score 8 if adjusted
2. Body mass index (BMI) at the time of breast-tissue composition assessment
Score 0 if not adjusted
9Score 4 if BMI measured >5yrs from breast-tissue composition assessment or if weight was used as a
proxy for BMI
Score 8 if adjusted for BMI close to time of breast-tissue composition assessment
3. How was BMI assessed?
Score 0 if not reported
Score 1 if self-reported
Score 2 if measured
4. Menopausal status
Score 0 if not adjusted
Score 2 if adjusted
5. OC / HT use at the time of breast-tissue composition assessment
Score 0 if not adjusted
Score 2 if adjusted
6. Other reproductive-related variables (e.g. menstrual phase, parity)
Score 0 if not adjusted
Score 1 if adjusted
More weights were given to the quality of the pre-natal exposure and breast-tissue composition data, and
adjustment for at least age and BMI at the time of breast-tissue composition assessment. For each parameter,
papers were assigned a score ranging as listed above. The overall quality of the study was expressed as the sum
of its parameter-specific scores, with possible scores ranging from 0 (lowest) to 59 (highest); the higher the score
the higher the methodological quality of the study and, hence, the lower the probability that its findings might
have been affected by bias.
1Table S1: Mutually-adjusted associations of MRI breast-tissue measurements in daughters, and
mammographic breast measurements in mothers, with age, anthropometry and hormone status at the
time of the breast examination
Relative change in geometric means (95% CI)
Total breast volume
(cm3) a
Total fat
volume
(cm3) a
Total water volume
(cm3) a Percent water
a
All participating daughters (n=483) b
Age at MRI (per 1 SD: 11 months) 1.00 (0.99, 1.00) 1.00 (0.99, 1.00) 0.99 (0.99, 1.00) 1.00 (1.00, 1.00)
BMI at MRI (per 1 SD: 4.3 kg/m2) 1.65 (1.58, 1.71) 1.86 (1.78, 1.95) 1.36 (1.31, 1.41) 0.83 (0.81, 0.84)
Menstrual phase
at MRI
Follicular 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Luteal 1.05 (0.90, 1.24) 1.06 (0.89, 1.27) 1.05 (0.89, 1.23) 1.00 (0.93, 1.06)
Irregular period 1.05 (0.94, 1.18) 1.06 (0·93, 1.20) 1.06 (0.94, 1.18) 1.00 (0.96, 1.05)
Hormone contraceptive 0.98 (0.81, 1.19) 1.02 (0·82, 1.26) 0.92 (0.76, 1.12) 0.94 (0.87, 1.02)
Breast area
(cm2)
Non-dense area
(cm2)
Dense area
(cm2) Percent density
Mothers with mammographic measurements
(n=164) c
Age at mammogram (per 1 SD: 3.9 yrs) 1.03 (0.97, 1.10) 0.79 (0.72, 0.87) 0.82 (0.75, 0.89) 0.79 (0.72, 0.87)
BMI at mammogram (per 1 SD: 4.7 kg/m2) 1.35 (1.28, 1.43) 0.72 (0.66, 0.78) 0.97 (0.89, 1.05) 0.72 (0.66, 0.78)
Parity at mammogram (per 1 SD: 0.86 children) 0.97 (0.92, 1.03) 1.05 (0.97, 1.14) 1.02 (0.95, 1.11) 1.05 (0.97, 1.14)
Menopausal status No 1 (ref) 1 (ref) 1 (ref) 1 (ref)
Yes 0.93 (0.78, 1.11) 0.96 (0.73, 1.26) 0.89 (0.69, 1.14) 0.96 (0.73, 1.26)
MRI: magnetic resonance imaging; CI: confidence intervals; BMI: body mass index; ref: reference category
a MRI and mammographic breast-tissue measurements were log transformed for the analysis and exponentiated estimated
regression parameters, with 95% CI calculated by exponentiating the original 95% CIs are presented. All daughters’ and
mothers’ variables were included simultaneously in their respective models.
b Data collected at the time of the MRI examination through the administration of a short questionnaire and measurements of
height and weight. See Table 1, footnote (a).
c Data collected at the clinical assessment or self-administered questionnaire conducted closest to the time of mammography
(median time interval: 3 years; IQR: 1.5 years).
2Table S2: Minimally-adjusted associations of MRI breast water percent in relation to maternal, in-utero,
and birth size characteristics using complete and imputed data (n=491), and Dixon-based MRI breast
water percent
Relative change in MRI breast water percent geometric means (95% CI) a
Complete data Imputed data (n=491) Dixon-based MRI breastwater percent (n=199)
n RC (95% CI) % RC (95% CI) n RC (95% CI)
Maternal characteristics (at participants
birth)
Maternal age of menarche per 1 SD 444 1.00 (0.98, 1.01) 1.00 (0.98, 1.01) 191 1.01 (0.98, 1.03)
Mother ever used contraceptive
pill
Yes 15 1 (ref) 96.2 1 (ref) 194 1 (ref)
No 439 0.99 (0.91, 1.09) 3.8 1.00 (0.91, 1.10) 2 1.07 (0.83, 1.39)
Age mother first used
contraceptive pill per 1 SD 430 1.00 (0.98, 1.01) 1.00 (0.98, 1.02) 192 1.00 (0.98, 1.03)
Mothers height per 1 SD 441 1.02 (1.01, 1.04) 1.03 (1.01, 1.05) 194 1.01 (0.99, 1.04)
Maternal age of first birth per 1 SD 458 0.99 (0.97, 1.01) 0.99 (0.97, 1.01) 199 1.00 (0.97, 1.02)
Mother age at participants birth per 1 SD 462 1.00 (0.98, 1.01) 1.00 (0.98, 1.01)
Mothers parity at participants
birth
0 225 1 (ref) 48.3 1 (ref) 93 1 (ref)
1 162 1.03 (0.99, 1.06) 35.2 1.03 (0.99, 1.06) 70 1.03 (0.97, 1.09)
2+ 75 1.02 (0.97, 1.06) 16.6 1.01 (0.97, 1.06) 34 1.01 (0.94, 1.08)
Mother pre-pregnancy weight
(BMI)
per 1 SD 425 1.00 (0.99, 1.02) 1.01 (0.99, 1.02) 187 1.02 (0.99, 1.04)
Under 13 1.05 (0.95, 1.16) 3.67 1.05 (0.95, 1.17) 4 0.93 (0.77, 1.11)
Healthy 351 1 (ref) 80.02 1 (ref) 159 1 (ref)
Over 67 1.03 (0.98, 1.08) 16.31 1.03 (0.98, 1.08) 24 1.02 (0.94, 1.11)
Maternal mother had breast
cancer
No 314 1 (ref) 1 (ref) 133 1 (ref)
Yes 42 1.00 (0.95, 1.07) 12.2 1.01 (0.96, 1.07) 21 1.03 (0.95, 1.12)
Average percent density (%) Q1 (<14) 45 1 (ref) 24 1 (ref)
Q2 (14-) 45 1.04 (0.96, 1.12) 23 0.97 (0.87, 1.07)
Q3 (25.2-) 44 1.06 (0.98, 1.15) 15 0.98 (0.88, 1.10)
Q4 (33.8-) 46 1.10 (1.02, 1.20) 21 1.00 (0.90, 1.11)
In-utero exposures
Placenta weight per 1 SD 121 1.01 (0.98, 1.04) 1.03 (0.99, 1.07) 52 1.00 (0.95, 1.05)
Absolute GWG (kg): wk 0 to
delivery per 1 SD 417 1.00 (0.98, 1.02) 1.00 (0.98, 1.02) 179 0.99 (0.96, 1.01)
Consumed alcohol during
pregnancy
No 117 1 (ref) 25.8 1 (ref) 58 1 (ref)
Yes 344 1.00 (0.96, 1.03) 74.2 1.00 (0.96, 1.04) 140 1.02 (0.97, 1.08)
Smoked tobacco during
pregnancy
No 414 1 (ref) 88.9 1 (ref) 180 1 (ref)
Yes 52 1.00 (0.95, 1.05) 11.1 1.00 (0.95, 1.06) 19 1.00 (0.92, 1.09)
Perinatal characteristics
Birthweight (g) per 1 SD 455 1.03 (1.02, 1.05) 1.03 (1.02, 1.05) 197 1.04 (1.01, 1.07)
Birth length (cm) per 1 SD 357 1.02 (1.00, 1.03) 1.02 (1.00, 1.04) 147 1.04 (1.01, 1.07)
Head circumference (cm) per 1 SD 365 1.02 (1.01, 1.04) 1.03 (1.01, 1.04) 151 1.04 (1.01, 1.07)
Ponderal Index (g/cm3) per 1 SD 353 1.01 (1.00, 1.03) 1.01 (1.00, 1.03) 145 1.01 (0.98, 1.04)
Gestational age (weeks)b <39 95 1 (ref) 20.4 1 (ref) 45 1 (ref)
39 103 1.00 (0.95, 1.05) 21.5 1.00 (0.95, 1.05) 39 1.01 (0.94, 1.10)
40 131 1.01 (0.96, 1.05) 27.9 1.01 (0.96, 1.05) 55 0.99 (0.92, 1.07)
41+ 140 1.01 (0.96, 1.05) 30.3 1.01 (0.96, 1.06) 62 0.97 (0.91, 1.04)
MRI: magnetic resonance imaging; SD: standard deviation; RC: relative percent change; CI: confidence intervals; BMI: body mass
index; GWG: gestational weight gain; Wk: week; ref: reference category
Models adjustments for age, standardised BMI and menstrual phase/ hormone contraceptive use at the time of the MRI examination
a MRI breast water percent measurements were log transformed for the analysis and exponentiated estimated regression
parameters, with CI calculated by exponentiating the original 95% CIs are presented.
b Data available only as a categorical variable
3Table S3: Systematic review of studies investigating the association between birth size measures, gestational age, and percent breast density
Author, Country &
Study year
Sample size,
Average age
(yrs)
MPD
assessment
method a
Source of birth
size data Outcome
Exposure
unit/
categories
Percent breast density
Covariates
All women Pre-menopausal Post-menopausal
Birthweight (g)
McCormack, UK 1999
(33)
1,294, 51.5
(SD=1.1)
Wolfe
grade Hospital records
OR for higher Wolfe
grade associated with
1 SD increase
1 SD 1.03 (0.92, 1.15)
Age
Anthropometry: measured BMI at 53 yrs
Breast size
Anderson, Denmark
1991-2001 (35)
8,271,
54.6
(SD=3.4)
Fatty vs·
mixed/dense
breast b
Parental reports
in childhood
OR fatty vs·
mixed/dense Continuous
OR1:
0.98 (0.90, 1.07)
OR2:
1.11 (1.02, 1.22)
Age
Other: birth cohort
For OR2: further adjusted for measured
BMI at age 13 yrs
Pearce, UK 1996-98
(50)
199, 51.5
(IQR: 50.7,
52.0)
Wolfe
grade Hospital records
OR for higher grade
associated with 1 SD
increase
z-score for
gestational
age and sex
1.32 (1.02, 1.71)
Age
Anthropometry: Measured BMI and
height at 49-51 yrs
Reproductive: age at menarche, age at
first pregnancy, menopausal status at
mammography, OC/HT use
Other: social class at birth and at 49-51
yrs, physical exercise and alcohol intake at
49-51 yrs, cigarette smoking
Lope, Spain 2007-08
(20)
3,557,
56
(SD=NK)
Boyd semi-
quantitative 6
categories
Self-reports in
adulthood
OR for higher
category associated
with unit increase
Smaller 0.77 (0.66, 0.98) 0.58 (0.37, 0.92) 0.84 (0.63, 1.12) Age
Anthropometry: BMI; pre-pubertal
height and pre-pubertal weight
Reproductive: age at menarche; parity,
menopausal status; maternal age at the
woman’s birth
Average 1 (ref) 1 (ref) 1 (ref)
Larger 0.94 (0.73, 1.21) 1.06 (0.63, 1.77) 0.88 (0.66,1.18)
Ekbom, Sweden 1988
(25)
370,
<60: 61%
Wolfe
grade Hospital records
OR for P2/DY vs·
N1/P1
<2500 0.97 (0.29, 3.28)
Age
Breast size
Other: maternal age at woman’s birth;
maternal SES; maternal parity, maternal
pre-eclampsia or eclampsia·
2500- 1 (ref)
3000- 1.03 (0.47, 2.27)
3500- 1.00 (0.45, 2.22)
4000+ 1.39 (0.56, 3.47)
P trend 0.53
Tamimi, Sweden
1993-94 (26)
893,
61.2 (SD: 6.8)
Computer
assisted Hospital records
Adjusted OR high
(≥50%) vs· low 
(<50%) categories
<3001 g 0.57 (0.18, 1.81)
Age
Anthropometric: BMI
Reproductive: parity; age at menopause
3001- 1 (ref·)
3501- 1.68 (0.78, 3.62)
>4000 2.91 (1.07, 7.88)
P trend 0.048
4Author, Country &
Study year
Sample size,
Average age
(yrs)
MPD
assessment
method a
Source of birth
size data Outcome
Exposure
unit/
categories
Percent breast density
Covariates
All women Pre-menopausal Post-menopausal
Jeffreys, Scotland
2008 (21)
590,
54.1 (range:
40.0, 71.5)
Computer
assisted
Self-reports in
adulthood
Adjusted OR high
(≥50%) vs· low 
(<50%) categories
<2500 g 0.27 (0·08, 0.87) 0.49 (0.06, 3.76) 0.20 (0.04, 0.97)
Age
2500- 1.32 (0·61, 2.88) 0.93 (0.24, 3.68) 1.55 (0.60, 4.03)
3000- 1 (ref) 1 (ref) 1 (ref)
≥4000 0.40 (0.17, 0.92) 0.20 (0.03, 1.41) 0.49 (0.19, 1.28) 
Cerhan, USA 2001
(22)
940,
Mean: 60.4
(SD=11.1)
Computer
assisted
Self-reports in
adulthood Adjusted mean
<2950 g 20.1 (19.0, 21.2) 33.4 (31.1, 35.7) 17.1 (15.9, 18.3) Age
Anthropometric: weight at first follow-up
(within 5 yrs from date of mammography
for >90% women)
Reproductive: age at menarche; age at
first birth; parity; menopausal status; OC
use; HT use
Other: educational level; alcohol use;
current smoking status; smoking history
2950- 21.0 (20.1, 22.0) 31.4 (30.0, 32.8) 19.8 (18.5, 21.0)
3380 22.9 (21.8, 24.0) 35.4 (33.2, 37.5) 20.2 (18.9, 21.4)
≥3750 23.0 (21.8, 24.1) 34.6 (32.6, 36.6) 21.0 (19.7, 22.3) 
P trend <0.01 0.19 <0.01
Lokate, The
Netherlands 1993-97
(51)
2,588,
50-70
Computer
assisted
Self-reports in
adulthood Adjusted mean PD
<2000 22.2 (19.2, 25.4) Age
Anthropometric: BMI, height, leg length
Reproductive: age at menarche, age at
first birth, parity, menopausal status, OC
use, HT use
Other: sub-study
2000- 21.7 (19.6, 23.9)
3000- 21.8 (20.2, 23.4)
4000+ 21.0 (18.9, 23.3)
P trend 0.532
Birth length (cm)
Ekbom, Sweden 1988
(25)
370,
<60: 61%
Wolfe
grade Hospital records
OR for P2/DY vs·
N1/P1
<49·5 cm 1 (ref)
Age
Breast size
Other: maternal age at woman’s birth;
maternal SES; maternal parity, maternal
pre-eclampsia or eclampsia·
49·5- 1.00 (0.52, 1.93)
51·0- 0.86 (0.46, 1.63)
≥52·5 1.37 (0.70, 2.68) 
P trend 0.52
Tamimi, Sweden
1993-94 (26)
893, 61.2
(SD: 6·8)
Computer
assisted Hospital records
Adjusted OR high
(≥50%) vs· low 
(<50%) categories
<50 0.77 (0.27, 2.21)
Age
Anthropometric: BMI
Reproductive: parity; age at menopause
50- 0.85 (0.29, 2.52)
51- 1 (ref)
52- 1.10 (0.37, 3.26)
≥53     1.04 (0.35, 3.11) 
P trend 0.49
Head circumference (cm)
Tamimi, Sweden
1993-94 (26)
893, 61.2
(SD: 6·8)
Computer
assisted Hospital records
Adjusted OR high
(≥50%) vs· low 
(<50%) categories
<34 cm 0.66 (0.23, 1.87)
Age
Anthropometric: BMI
Reproductive: parity; age at menopause
34- 0.90 (0.33, 2.44)
35- 1 (ref)
≥36     1.72 (0.68, 4.35) 
P trend 0.04
5Author, Country &
Study year
Sample size,
Average age
(yrs)
MPD
assessment
method a
Source of birth
size data Outcome
Exposure
unit/
categories
Percent breast density
Covariates
All women Pre-menopausal Post-menopausal
Gestational age
Pearce, UK 1996-98
(50)
199, 51.5
(IQR: 50.7,
52.0)
Wolfe grade Hospital records
OR for higher grade
associated with 1 SD
increase
Continuous 0.97 (0.79, 1.19) Unadjusted
Lope, Spain 2007-08
(20)
3490
56
(SD=NK)
Boyd semi-
quantitative 6
categories
Self-reports in
adulthood
OR for higher
category associated
with unit increase
Not
premature 1 (ref)
Age
Anthropometry: BMI
Reproductive: parity, menopausal statusPremature 0.80 (0.58, 1.12)
Cerhan, USA 2001 (22)
862,
Mean: 60.4
(SD=11·1)
940,
Mean: 60.4
(SD=11·1)
Computer
assisted
Self-reports in
adulthood
Pre-term 19.2 (17.3, 21.1) 30.5 (26.9, 34.0) 16.7 (14.4, 19.0) AgeAnthropometric: weight at first follow-up
(within 5 yrs from date of mammography
for >90% women)
Reproductive: age at menarche; age at
first birth; parity; menopausal status; OC
use; HT use
Other: educational level; alcohol use;
current smoking status; smoking history
Term 22.0 (21.4, 22.6) 33.3 (32.2, 34.4) 20.2 (19.5, 21.0)
Post-term 23.7 (20.9, 26.5) 34.7 (30.3, 39.0) 23.0 (19.2, 26.8)
P trend 0.07 0.25 0.07
Lokate, The Netherlands
1993-97 (51) 1,378, 50-70
Computer
assisted
Self-reports in
adulthood Adjusted mean PD
Pre-term (>2
weeks early) 22.3 (19.5, 25.4)
Age
Anthropometric: BMI, height, leg length
Reproductive: age at menarche, age at
first birth, parity, menopausal status, OC
use, HT use
Other: sub-study
Term 21.0 (19.4, 22.7)
Post-term (>2
weeks late) 21.3 (17.9, 25.0)
BMI: body mass index; HT: hormone therapy; MPD: mammographic percent density; OC: oral contraceptives; OR: odds ratio; ref: reference category; SES: socio-economic status; SD: standard deviation
a All studies in the review that examined associations with birth size and gestational age were based on mammographic assessment of breast density performed on analogue films.
b Fatty breast was equivalent to BI-RADS (2008) density code 1 and part of code 2; Mixed/dense breast, equivalent to part of BI-RADS code 2, 3, or 4.
6Table S4: Systematic review of studies investigating the association between maternal and in-utero exposures and percent breast density
Author,
Country &
Study year
Sample size &
Average age
Breast-tissue
composition
assessment
Exposure
source Outcome Exposure
Percent breast density
Covariates
All women Pre-menopausal Post-menopausal
Maternal percent density
Boyd, USA
2003-07 (12)
306 D-M pairs,
D: 20.8
(SD=4.9); M:
50.9 (4.9)
Semi-
automated
percent water
on Dixon
MRI images
Computer-
assisted
mammograp
hic percent
density
Relative
change in
percent water
for unit
increase
Maternal
mammo-graphic
percent density
0·.17
Age (D and M)
Anthropometry (weight and height for D
and M)
Reproductive (D only): age at menarche,
current OC use
Other (D only): physical activity
P trend <0.0001
Maskarinec,
USA (24)
101 D-M pairs
(plus 12 mothers
had 2 D), M:
47.7 (SD=4.8)
D: 13.9
(SD=1.7)
Computer
assisted on
DXA images
Maternal
DXA
percent
density
Regression
coefficients
for 1 SD
increase in
exposure
Maternal DXA
fibroglan-dular
percent (%)
-0.04 Age (D and M)
Anthropometry: DXA % total body fat
(D and M)
Other (D only): ethnicity and Tanner
breast stage
P trend 0.53
Maternal age
Lope, Spain
2007-08 (20)
3,584,
45-68y
Boyd semi-
quantitative
6 scale
Retrospectiv
e self-report
OR for higher
category
associated
with unit
increase
Maternal age
(yrs)
<30 1 (ref) 1 (ref) 1 (ref) Age
Anthropometric: BMI, height, leg length
Reproductive: age at menarche, age at
first birth, parity, menopausal status, OC
use, HT use
Other: sub-study
30- 1.01 (0.87, 1.14) 1.00 (0.72, 1.38) 1.00 (0.84, 1.18)
35- 1.05 (0.87, 1.27) 1.15 (0.80, 1.66) 1.04 (0.84, 1.29)
>39 1.28 (1.03, 1.60) 1.20 (0.74, 1.93) 1.32 (1.03, 1.70)
5-year trend 1.04 (0.99, 1.10) 1.06 (0.95, 1.18) 1.04 (0.98, 1.10)
Ekbom,
Sweden 1988
(25)
370,
<60: 61%
Wolfe
grade
Hospital
records
OR for
P2/DY vs·
N1/P1
Continuous
maternal age
(yrs)
Per 1-year
increment 0.98 (0.94, 1.02)
Age
Breast size
Other: maternal age at woman’s birth;
maternal SES; maternal parity, maternal
pre-eclampsia or eclampsia·
Cerhan, USA
2001 (22)
1,550
Mean: 60.4
(SD=11.1)
940,
Mean: 60.4
(SD=11·1)
Computer
assisted
Self-reports
in adulthood
Maternal age
(yrs)
<19 20.8 (19.1, 22.5) 32·5 (28·8, 36·2) 18.9 (17.1, 20.6) Age
Anthropometric: weight at first follow-
up (within 5yrs from date of
mammography for >90% women)
Reproductive: age at menarche; age at
first birth; parity; menopausal status; OC
use; HT use;
Other: educational level; alcohol use;
current smoking status; smoking history
20- 20.6 (19.8, 21.4) 31·8 (30·1, 33·4) 19.0 (18.0, 19.9)
25- 22.2 (21.4, 23.1) 33·6 (32·0, 35·3) 20.5 (19.5, 21.5)
30- 20.7 (19.8, 21.6) 31·9 (29·9, 33·8) 19.0 (18.0, 19.9)
≥35 21.6 (20.7, 22.5) 33·8 (32·0, 35·5) 19.7 (18.7, 20.7) 
P trend 0.42 0.65 0.49
Lokate, The
Netherlands
1993-97 (51)
2,468, 50-70 Computerassisted
Self-reports
in adulthood
Adjusted
mean PD
Continuous
maternal age
(yrs)
≤25    20.3 (18.6, 22.0) Age
Anthropometric: BMI, height, leg length
Reproductive: age at menarche, age at
first birth, parity; menopausal status, OC
use, HT use
Other: sub-study, paternal age
26- 20.6 (19.1, 22.2)
30- 20.7 (19.2, 22.3)
>33 21.2 (19.5, 22.9)
P trend 0.391
7Author,
Country &
Study year
Sample size &
Average age
Breast-tissue
composition
assessment
Exposure
source Outcome Exposure
Percent breast density
Covariates
All women Pre-menopausal Post-menopausal
Maternal parity
Ekbom,
Sweden 1988
(25)
370,
<60: 61% Wolfegrade
Hospital
records
OR for
P2/DY vs·
N1/P1
Maternal parity
1 1 (ref) AgeBreast size
Other: maternal age at woman’s birth;
maternal SES; maternal parity, maternal
pre-eclampsia or eclampsia·
≥2 1.24 (0.74, 2.07)   
Cerhan,
USA, 2001
(22)
1636,
Mean: 60.4
(SD=11.1)
Computer
assisted
Self-reports
in adulthood
Adjusted
mean Birth rank
1st child 21.1 (20.3, 21.9) 32.5 (30.8, 34.2) 19.3 (18.4, 20.2) Age
Anthropometric: weight at first follow-
up (within 5yrs from date of
mammography for >90% women)
Reproductive: age at menarche; age at
first birth; parity; menopausal status; OC
use; HT use;
Other: educational level; alcohol use;
current smoking status; smoking history
2nd child 21.3 (20.4, 22.3) 35.8 (34.1, 37.5) 18.7 (17.6, 19.7)
3rd child 21.5 (20.4, 22.5) 33.3 (31.4, 35.2) 19.8 (18.6, 21.0)
4th child 22.0 (20.9, 23.1) 32.4 (30.1, 34.8) 20.6 (19.4, 21.9)
>5th child 20.7 (19.9, 21.6) 32.3 (30.5, 34.2) 19.2 (18.3, 20.1)
P trend 0.91 0.39 0.39
Lokate, The
Netherlands
1993-97 (48)
2,527, 50-70 Computer
assisted
Self-reports
in adulthood
Adjusted
mean PD Birth rank
Eldest 20.7 (19.3, 22.2)
Age
Anthropometric: BMI, height, leg length
Reproductive: age at menarche, age at
first birth, parity, menopausal status, OC
use, HT use
Other: sub-study
2- 20.5 (19.2, 21.8)
6- 20.6 (18.8, 22.4)
>10 20.2 (16.2, 24.7)
P trend 0.740
Continuous 0.01 (-0.01, 0.03)
Prenatal exposure to cigarette smoke
Cerhan, USA
2001 (22)
1,553,
Mean: 60.4
(SD=11·1)
Computer
assisted
Self-reports
in adulthood
Adjusted
mean
Mother smoked
in pregnancy
No 21.3 (20.8, 21.7) 32.6 (31.6, 33.6) 19.5 (19.1, 20.0)
Age
Anthropometric: weight at first follow-
up (within 5yrs from date of
mammography for >90% women)
Reproductive: age at menarche; age at
first birth; parity; menopausal status; OC
use; HT use
Other: educational level; alcohol use;
current smoking status; smoking history
Yes 20.9 (19.4, 22.3) 33.2 (31.4, 35.0) 17.6 (15.5, 19.8)
Terry, USA
(23)
678;
44·1y (SD=2.3)
Computer
assisted
Parental
reports in in-
utero
Absolute
change for
unit increase
in exposure
Pre-natal
exposure to
smoking
No 1 (ref)
Age
Anthropometric: BMI
Other: birth weight, birth length, age at
menarche, maternal education; adult
smoking status
Yes -2.72 (-5.68, 0.24)
Maternal no·
packs of
cigarettes/ day
None 1 (ref)
Age
Anthropometric: BMI
Other: maternal education; adult smoking
status
0- -2.05 (-5.11, 1.02)
½- -2.01 (-5.66, 1.64)
≥1 pack -3.74 (-7.11, -0.37)
P trend 0.02
8Author,
Country &
Study year
Sample size &
Average age
Breast-tissue
composition
assessment
Exposure
source Outcome Exposure
Percent breast density
Covariates
All women Pre-menopausal Post-menopausal
Prenatal exposure to alcohol
Cerhan, USA
2001 (22)
1,331, Mean: 60.4
(SD=11.1) Computerassisted
Self-reports
in adulthood
Adjusted
mean
Mother drank
alcohol during
pregnancy
No 21.2 (20.7, 21.6) 32.6 (31.6, 33.6) 19.4 (18.9, 19.9)
Age
Anthropometric: weight at first follow-
up (within 5yrs from date of
mammography for >90% women)
Reproductive: age at menarche; age at
first birth; parity; menopausal status; OC
use; HT use
Other: educational level; alcohol use;
current smoking status; smoking history
Yes 21.4 (19.7, 23.2) 33.1 (30.9, 35.2) 20.0 (17.4, 22.6)
Placental weight
Ekbom,
Sweden 1988
(25)
370,
<60: 61% Wolfegrade
Hospital
records
OR for
P2/DY vs·
N1/P1
Placenta weight
(g)
<550 g 1 (ref) Age
Breast size
Other: maternal age at woman’s birth;
maternal SES; maternal parity, maternal
pre-eclampsia or eclampsia·
550- 1.67 (0.83, 3.40)
630- 1.76 (0.89, 3.45)
730+ 2.34 (1.17, 4.68)
P trend 0.02
D: daughters; M: Mothers; MPD: mammographic percent density; MRI; magnetic resonance imaging; DXA: dual X-ray absorptiometry; BMI: body mass index; HT: hormone therapy; MD:
mammographic density; OC: oral contraceptives; OR: odds ratio; ref·: reference category; SES: socio-economic status; SD: standard deviation
1Figure S1: Correlation between participants’ MRI breast-tissue measurements and their mothers’ mammographic
density measurements (n=164)
MRI: magnetic resonance imaging; r: Pearson’s correlation coefficient
2Figure S2: Predicted MRI breast percent water geometric means in relation to categories of maternal height,
maternal mammographic percent density, and participant’s size at birth (minimally-adjusted estimates)
MRI: magnetic resonance imaging
MRI breast measures were log transformed, and exponentiated estimated regression parameters, with 95% confidence
intervals (CI) calculated by exponentiating the original 95% Cis are presented.
Models adjusted for the participant’s age, BMI and menstrual phase/hormone contraceptive use at MRI and, where
appropriate, mother’s age and BMI at mammography. Continuous variables were centred at the mean.
3Figure S3: PRISMA flow diagram of the systematic review
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4Figure S4: Funnel plots for the meta-analysis of birth weight (A: n studies = 9; and B: n=8) and maternal age (C: n=5) and percent breast density
The fitted line corresponds to the Egger regression test for funnel-plot asymmetry
Publication bias corresponds to the Egger test, the null hypothesis being that the funnel plot is symmetrical. Evidence against the null hypothesis indicates that there is a linear
association between effect size and its standard error, indicating publication bias
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